Aptevo Therapeutics completes 1-for-37 reverse stock split effective December 3, 2024

Aptevo Therapeutics Inc.

Certificate of Amendment filed with Delaware; split effective at 5:01 p.m. ET on December 3, 2024.
Every 37 pre-split shares combined into one share; par value unchanged; no fractional shares issued.
Trading on Nasdaq Capital Market begins on split-adjusted basis December 4, 2024; new CUSIP 03835L 405.
Proportionate adjustments made to stock options, RSUs, warrants, and equity plan reserves.
Stockholders' percentage ownership unchanged except for fractional share cash payments.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Aptevo Therapeutics Inc.: Amended certificate of incorporation to effect a 1-for-37 reverse stock split (effective 2024-12-03).

Change: charter amendment
Effective: 2024-12-03

Exact text from the filing

Accordingly, on December 2, 2024, the Company filed a Certificate of Amendment of Amended and Restated Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to effect the Reverse Stock Split. The Amendment was effective at 5:01 p.m. Eastern Time on December 3, 2024 (the “Effective Time”).

View on SEC.gov

Browse all governance changes →

Aptevo Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-132855

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.